During a Case-Based Roundtable® event, Robert Z. Orlowski, MD, PhD, discussed the case of a patient who had progression of multiple myeloma after quadruplet frontline with transplant.
The second act of a popular reprogramming factor could maximize the potential of iPSCs in research and regenerative medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback